| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A+AVD versus eBEACOPP in advanced-stage Hodgkin lymphoma
|
Diehl, Louis F
|
|
|
8 |
6 |
p. e384-e386
|
artikel
|
| 2 |
Anti-CD25 antibody–drug conjugates: improving the delivery of death to lymphoma cells?
|
Schmitz, Norbert
|
|
|
8 |
6 |
p. e387-e389
|
artikel
|
| 3 |
Bleeding disorders: adapting to change
|
The Lancet Haematology,
|
|
|
8 |
6 |
p. e383
|
artikel
|
| 4 |
Brentuximab vedotin with chemotherapy for stage III or IV classical Hodgkin lymphoma (ECHELON-1): 5-year update of an international, open-label, randomised, phase 3 trial
|
Straus, David J
|
|
|
8 |
6 |
p. e410-e421
|
artikel
|
| 5 |
Camidanlumab tesirine in patients with relapsed or refractory lymphoma: a phase 1, open-label, multicentre, dose-escalation, dose-expansion study
|
Hamadani, Mehdi
|
|
|
8 |
6 |
p. e433-e445
|
artikel
|
| 6 |
CAR T-cell therapy for multiple myeloma: state of the art and prospects
|
van de Donk, Niels W C J
|
|
|
8 |
6 |
p. e446-e461
|
artikel
|
| 7 |
Correction to Lancet Haematol 2021; 8: e185–93
|
|
|
|
8 |
6 |
p. e393
|
artikel
|
| 8 |
Correction to Lancet Haematol 2021; 8: e205–15
|
|
|
|
8 |
6 |
p. e393
|
artikel
|
| 9 |
Dynamics of minimal residual disease in patients with multiple myeloma on continuous lenalidomide maintenance: a single-arm, single-centre, phase 2 trial
|
Diamond, Benjamin
|
|
|
8 |
6 |
p. e422-e432
|
artikel
|
| 10 |
Eliminating race-based reference ranges in haematology: a call to action
|
Weyand, Angela C
|
|
|
8 |
6 |
p. e462-e466
|
artikel
|
| 11 |
From working in the corporate world to nursing to advocacy
|
Nsofwa, Agnes
|
|
|
8 |
6 |
p. e395
|
artikel
|
| 12 |
Global collaboration led by the EBMT Nurses Group
|
Trigoso, Eugenia
|
|
|
8 |
6 |
p. e396-e397
|
artikel
|
| 13 |
Maintaining the minimal: dynamics of measurable residual disease with continuous lenalidomide therapy
|
Bal, Susan
|
|
|
8 |
6 |
p. e386-e387
|
artikel
|
| 14 |
Matthew Fowler: driving advanced nursing practice in haematology
|
Siva, Nayanah
|
|
|
8 |
6 |
p. e394
|
artikel
|
| 15 |
PET-guided eBEACOPP treatment of advanced-stage Hodgkin lymphoma (HD18): follow-up analysis of an international, open-label, randomised, phase 3 trial
|
Kreissl, Stefanie
|
|
|
8 |
6 |
p. e398-e409
|
artikel
|
| 16 |
Response to first vaccination against SARS-CoV-2 in patients with multiple myeloma
|
Bird, Sarah
|
|
|
8 |
6 |
p. e389-e392
|
artikel
|
Tijdschrift beschrijving